Convalescent Plasma Therapy and COVID-19: A Scientometric Analysis
Loading...
Files
Date
2022-11
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
INFLIBNET Centre, Gandhinagar
Abstract
Call to action condition during COVID-19 epidemic outbreak, where no specific antiviral agents
were available to treat, convalescent plasma transfusion was used worldwide to prevent severity
and disease progression. Since the late 19th century, convalescent plasma therapy was used worldwide
to weaken several outbreaks caused by human respiratory viruses like 1918 Spanish flu pandemic,
1958 Argentine hemorrhagic fever in Argentina, 2003 SARS epidemic (SARS-CoV-1), and 2019
COVID-19 pandemic.
This scientometric analysis focuses on the research done on CP therapy and COVID-19 during 2019
to 2022 to know the most productive authors with their affiliation, keyword analysis and highly
cited publications to get overview of research progress. A total of 1,56,071 publications was found
in Web of Science for the years 2019 to 2022. VoSViewer and Bibliometrix R were used for data
analysis. Harvard Medical School having highest publications. USA, China, UK, Italy, India, Germany,
Canada, Australia, Iran and France are the top 10 contributing countries.
Purpose: COVID-19 virus outbreak all over the world. An increasing number of researches for the
use of CP therapy in COVID-19 patients are upcoming research and this report aims at performing
scientometric analysis of all the available researches to get the detailed analysis.
Description
13th International CALIBER-2022, BHU, Varanasi, UP, 17-19 November 2022
Keywords
Scientometric Analysis, Convalescent Plasma Therapy, Serum Therapy, Covid-19, SARS-COV-19